| scholarly article | Q13442814 |
| P356 | DOI | 10.1152/JN.1999.82.6.3575 |
| P698 | PubMed publication ID | 10601483 |
| P2093 | author name string | G Bernardi | |
| P Giacomini | |||
| P Calabresi | |||
| D Centonze | |||
| P Gubellini | |||
| B Picconi | |||
| P433 | issue | 6 | |
| P304 | page(s) | 3575-3579 | |
| P577 | publication date | 1999-12-01 | |
| P1433 | published in | Journal of Neurophysiology | Q1709863 |
| P1476 | title | Unilateral dopamine denervation blocks corticostriatal LTP | |
| P478 | volume | 82 |
| Q36851718 | A comparison of the subsecond dynamics of neurotransmission of dopamine and serotonin |
| Q36628908 | A convergent model for cognitive dysfunctions in Parkinson's disease: the critical dopamine-acetylcholine synaptic balance. |
| Q53421741 | A silent eligibility trace enables dopamine-dependent synaptic plasticity for reinforcement learning in the mouse striatum. |
| Q28680729 | A unified framework for addiction: vulnerabilities in the decision process |
| Q44931344 | Abnormal Ca2+-calmodulin-dependent protein kinase II function mediates synaptic and motor deficits in experimental parkinsonism. |
| Q42439882 | Altered long-term corticostriatal synaptic plasticity in transgenic mice overexpressing human CU/ZN superoxide dismutase (GLY(93)-->ALA) mutation |
| Q34328619 | An outline of brain function |
| Q82029272 | Anatomy and physiology of the basal ganglia: relevance to Parkinson's disease and related disorders |
| Q37778900 | Assemblies of glutamate receptor subunits with post-synaptic density proteins and their alterations in Parkinson's disease |
| Q36662702 | Association of protein phosphatase 1 gamma 1 with spinophilin suppresses phosphatase activity in a Parkinson disease model. |
| Q34392437 | Basal ganglia dysfunction in Tourette's syndrome: a new hypothesis |
| Q28392932 | Calcium-dependent inactivation of calcium channels in the medial striatum increases at eye opening |
| Q36909436 | Catecholaminergic based therapies for functional recovery after TBI |
| Q37117817 | Cdk5 Modulates Long-Term Synaptic Plasticity and Motor Learning in Dorsolateral Striatum |
| Q38245731 | Cerebellum in levodopa-induced dyskinesias: the unusual suspect in the motor network |
| Q45072843 | Chronic haloperidol promotes corticostriatal long-term potentiation by targeting dopamine D2L receptors. |
| Q46450404 | Chronic oral nicotine normalizes dopaminergic function and synaptic plasticity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates. |
| Q36542313 | Continuous dopamine-receptor treatment of Parkinson's disease: scientific rationale and clinical implications |
| Q43073344 | Decreased striatal dopamine release underlies increased expression of long-term synaptic potentiation at corticostriatal synapses 24 h after 3-nitropropionic-acid-induced chemical hypoxia |
| Q42852538 | Distinct levels of dopamine denervation differentially alter striatal synaptic plasticity and NMDA receptor subunit composition. |
| Q28185479 | Distinct roles of D1 and D5 dopamine receptors in motor activity and striatal synaptic plasticity |
| Q28570291 | Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking |
| Q63256021 | Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity |
| Q28579756 | Dopamine depletion alters phosphorylation of striatal proteins in a model of Parkinsonism |
| Q37685684 | Dopamine receptor agonists in the treatment of advanced Parkinson's disease |
| Q43673182 | Dopamine responses comply with basic assumptions of formal learning theory |
| Q34951521 | Dopamine-dependent plasticity of corticostriatal synapses |
| Q35184819 | Dopamine: a potential substrate for synaptic plasticity and memory mechanisms |
| Q36899781 | Dopaminergic mechanisms in actions and habits |
| Q36577320 | Drug insight: Continuous dopaminergic stimulation in the treatment of Parkinson's disease |
| Q35945732 | Effects of subthalamic nucleus stimulation on motor cortex plasticity in Parkinson disease |
| Q34070888 | Electrophysiology of dopamine in normal and denervated striatal neurons |
| Q38018946 | Endocannabinoid modulation of dopaminergic motor circuits. |
| Q43662825 | Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine. |
| Q42195693 | Intensive rehabilitation treatment in parkinsonian patients with dyskinesias: a preliminary study with 6-month followup |
| Q41836234 | Inter-synaptic learning of combination rules in a cortical network model |
| Q35955621 | Intrastriatal dopamine D1 antagonism dampens neural plasticity in response to motor cortex lesion |
| Q48325450 | L-DOPA, dyskinesia and striatal plasticity |
| Q35424424 | L-DOPA-Induced Dyskinesia and Abnormal Signaling in Striatal Medium Spiny Neurons: Focus on Dopamine D1 Receptor-Mediated Transmission |
| Q27002626 | Levodopa-induced plasticity: a double-edged sword in Parkinson's disease? |
| Q30011083 | Long-term potentiation in an avian basal ganglia nucleus essential for vocal learning. |
| Q44383212 | Loss of bidirectional striatal synaptic plasticity in L-DOPA-induced dyskinesia |
| Q43581244 | Modeling functions of striatal dopamine modulation in learning and planning. |
| Q41073091 | Models of Acetylcholine and Dopamine Signals Differentially Improve Neural Representations |
| Q38739709 | Motor learning in animal models of Parkinson's disease: Aberrant synaptic plasticity in the motor cortex |
| Q35674337 | Neurobiology of Tourette's syndrome: concepts of neuroanatomic localization and neurochemical abnormalities |
| Q38038559 | New synaptic and molecular targets for neuroprotection in Parkinson's disease |
| Q43940157 | Nicotinic acetylcholine receptors interact with dopamine in induction of striatal long-term depression. |
| Q33589580 | Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesis |
| Q30497250 | Presynaptic BDNF promotes postsynaptic long-term potentiation in the dorsal striatum |
| Q34044620 | Priming for l-dopa-induced dyskinesia in Parkinson's disease: a feature inherent to the treatment or the disease? |
| Q35028568 | Region-specific restoration of striatal synaptic plasticity by dopamine grafts in experimental parkinsonism |
| Q30524906 | Reinforcement, dopamine and rodent models in drug development for ADHD |
| Q35003324 | Roles for nigrostriatal--not just mesocorticolimbic--dopamine in reward and addiction |
| Q34332773 | Selective effects of dopamine depletion and L-DOPA therapy on learning-related firing dynamics of striatal neurons |
| Q64100042 | Sleep-State Dependent Alterations in Brain Functional Connectivity under Urethane Anesthesia in a Rat Model of Early-Stage Parkinson's Disease |
| Q34461816 | Stepping out of the box: information processing in the neural networks of the basal ganglia |
| Q37925513 | Striatal Signaling in L-DOPA-Induced Dyskinesia: Common Mechanisms with Drug Abuse and Long Term Memory Involving D1 Dopamine Receptor Stimulation. |
| Q37336143 | Striatal plasticity and basal ganglia circuit function |
| Q52371217 | Synaptic plasticity and levodopa-induced dyskinesia: electrophysiological and structural abnormalities. |
| Q37040227 | Synaptic targets of Δ9-tetrahydrocannabinol in the central nervous system. |
| Q35720254 | Targeting Dopamine in Acute Traumatic Brain Injury |
| Q37909050 | The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines |
| Q37364849 | The hypothesis of the genesis of motor complications and continuous dopaminergic stimulation in the treatment of Parkinson's disease |
| Q44082268 | Theta burst stimulation over the primary motor cortex does not induce cortical plasticity in Parkinson's disease |
Search more.